Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Equillium (0FY) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:0FYEquilliumEUR 0.93EUR 84.03M-6.0110.56%Strong BuyUnlock the DE:0FY analyst price target with TipRanks PremiumDE:0FYUnlock the DE:0FY top-analyst price target with TipRanks Premium
NRXPNRX Pharmaceuticals$2.15$113.04M-4.115.91%Strong BuyUnlock the NRXP analyst price target with TipRanks PremiumDE:0FY vs NRXPUnlock the NRXP top-analyst price target with TipRanks Premium
STROSutro Biopharma$8.60$144.76M-0.681.58%Strong BuyUnlock the STRO analyst price target with TipRanks PremiumDE:0FY vs STROUnlock the STRO top-analyst price target with TipRanks Premium
HYFTMindWalk Holdings$0.68$37.98M-2.69-61.36%Strong BuyUnlock the HYFT analyst price target with TipRanks PremiumDE:0FY vs HYFTUnlock the HYFT top-analyst price target with TipRanks Premium
PRLDPrelude Therapeutics$3.23$260.48M-4.97101.87%Strong BuyUnlock the PRLD analyst price target with TipRanks PremiumDE:0FY vs PRLDUnlock the PRLD top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:0FYEquillium0.930.1012.29%
NRXPNRX Pharmaceuticals2.150.020.94%
STROSutro Biopharma8.600.171.98%
HYFTMindWalk Holdings0.68-0.99-59.04%
PRLDPrelude Therapeutics3.231.5693.41%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts